scispace - formally typeset
D

Deling Kong

Researcher at Nankai University

Publications -  422
Citations -  22173

Deling Kong is an academic researcher from Nankai University. The author has contributed to research in topics: Mesenchymal stem cell & Stem cell. The author has an hindex of 65, co-authored 388 publications receiving 16515 citations. Previous affiliations of Deling Kong include Peking Union Medical College & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts

TL;DR: Mesenchymal stem cells genetically enhanced with Akt1 can repair infarcted myocardium, prevent remodeling and nearly normalize cardiac performance.
Journal ArticleDOI

Isolation and Transplantation of Autologous Circulating Endothelial Cells Into Denuded Vessels and Prosthetic Grafts. Implications for Cell-Based Vascular Therapy

TL;DR: It is concluded that transplantation of EPCs may play a crucial role in reestablishing endothelial integrity in injured vessels, thereby inhibiting neointimal hyperplasia and implications for novel and practical cell-based therapies for vascular disease.
Journal ArticleDOI

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.

TL;DR: In this paper, the authors evaluated the efficacy of intravenous infusion of genetically modified mesenchymal stem cells (MSCs) overexpressing CXC chemokine receptor 4 (CXCR4).

Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance

TL;DR: In summary, intravenous delivery of genetically modified MSCs expressing CXCR4 may be a useful, non-invasive, and safe therapeutic strategy for post-infarction myocardial repair.